Overview

Minimizing Pain During Office Intradetrussor Botox Injection

Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
This will be a prospective double-blinded randomized controlled trial comparing two pre-treatment protocols for patients undergoing intradetrussor botox injections to determine if a buffered lidocaine solution offers superior pain control.
Phase:
Phase 4
Details
Lead Sponsor:
Boston Urogynecology Associates
Treatments:
Lidocaine